Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
0.7600
-0.0401 (-5.01%)
At close: Apr 1, 2025, 4:00 PM
0.7590
-0.0010 (-0.13%)
After-hours: Apr 1, 2025, 4:47 PM EDT
Milestone Pharmaceuticals Employees
Milestone Pharmaceuticals had 33 employees as of December 31, 2024. The number of employees decreased by 14 or -29.79% compared to the previous year.
Employees
33
Change (1Y)
-14
Growth (1Y)
-29.79%
Revenue / Employee
n/a
Profits / Employee
-$1,258,152
Market Cap
50.36M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MIST News
- 4 days ago - Milestone Pharmaceuticals Shares Hit New Low After FDA Rejects Etripamil - Market Watch
- 4 days ago - US FDA declines to approve Milestone Pharma's heart rhythm nasal spray - Reuters
- 4 days ago - FDA Issues Complete Response Letter for Etripamil for PSVT - GlobeNewsWire
- 11 days ago - Milestone Pharmaceuticals: A Compelling Value Proposition For Patients And Payers - Seeking Alpha
- 12 days ago - Milestone Pharmaceuticals to Present Clinical Data on Etripamil at the American College of Cardiology - GlobeNewsWire
- 19 days ago - Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire
- 4 weeks ago - Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Milestone® Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire